Skip to main content
Equibles
VKTX logo

VKTX · Viking Therapeutics, Inc. · Metrics

Track VKTX — free

Use VKTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VKTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$26.73 +0.02 (+0.07%)
Russell 1000 member Rebalance outlook locked
Market Cap
$3.12B
Shares
116.65M
Volume · Oct 21 1.87M Avg daily vol (3M) 4.51M

VKTX metrics

69 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$26.71
Market cap
$3.12B

Price action

20 metrics
Price change (1W)
+0.2%
Price change (30D)
-11.3%
Price change (3M)
-29.6%
Price change (6M)
-21.0%
Price change (YTD)
-24.1%
Price change (1Y)
-20.9%
Trailing year
Price change (5Y)
+359.7%
52-week high
$42.13
52-week low
$25.05
Change from 52-week high
-36.6%
Change from 52-week low
+6.6%
Annualized volatility
69.3%
Annualized volatility (3M)
91.2%
Beta
1.2
RSI (14D)
41.6
Price vs SMA 50
-16.1%
Price vs SMA 200
-18.2%
Avg volume (3M)
4.51M
Relative volume
1.0
Average dollar volume
$151.29M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
116.65M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
7.4
reciprocal yield 13.5%
FCF yield
—
TTM · current market cap
Buyback yield
0.2%
P / FCF
—
P / operating cash flow
—
Earnings yield
-17.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$560.02M
Net income (TTM)
−$534.80M
Trailing 12 months
Diluted EPS (TTM)
$-4.67
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-4.88
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-4.66
Operating cash flow per diluted share (TTM)
$-3.65
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$4.44
Stock compensation per diluted share (TTM)
$0.33
Book value per share
$5.57

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-131.0%
Return on assets
-102.5%
Debt / equity
0.0
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$125.75M
Latest balance sheet
Cash & equivalents
$125.75M
Total assets
$521.90M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$418.44M
Capital expenditures (TTM)
—
R&D (TTM)
$509.31M
SG&A (TTM)
—
Stock compensation (TTM)
$37.39M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
442
13F filer change QoQ
+23
Institutional ownership
73.9%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
17.3%
Private-fund adviser ownership
13.2%
Active holders' share change QoQ
+3.0%
Holder tenure
13.8
Price vs estimated holder cost
+13.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.5%

Short interest

3 metrics
Short interest
22.2%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.27M
Insider-sentiment score
13 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1607678 CUSIP 92686J106 13F (30d) 54 filings 50 filers Visit website Investor relations